The Effectiveness of Shimbuto and Ninjinto Japanese Kampo Herbal Medicines in combination with Pegylated interferon alpha plus ribavirin for patients with chronic hepatitis C A pilot study
Not Applicable
Completed
- Conditions
- Chronic hepatitis C
- Registration Number
- JPRN-UMIN000007068
- Lead Sponsor
- Department of General Internal Medicine, Kyushu University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Exclusion criteria are follows 1)concomitant liver disease (hepatitis B surface antigen positive or Human immunodeficiency virus positive) 2)clinical or biochemical evidence of hepatic decompensation, advanced cirrhosis 3)excessive active alcohol consumption>60g/day or drug abuse 4)evidence of hepatocellula carcinoma 5) antiviral or immunosuppressive treatment within 12 months prior to enrollment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method VIrological response rate by Abbott RealTime PCR
- Secondary Outcome Measures
Name Time Method